Synthesis, Anticancer Evaluation and Structure-Activity Analysis of Novel (<i>E</i>)- 5-(2-Arylvinyl)-1,3,4-oxadiazol-2-yl)benzenesulfonamides
To learn more about the structure−activity relationships of (<i>E</i>)-3-(5-styryl-1,3,4-oxadiazol-2-yl)benzenesulfonamide derivatives, which in our previous research displayed promising in vitro anticancer activity, we have synthesized a group of novel (<i>E</i>)-5...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/6/2235 |
id |
doaj-50862adfbcfc4a9ebe25d2e00bfa7ea0 |
---|---|
record_format |
Article |
spelling |
doaj-50862adfbcfc4a9ebe25d2e00bfa7ea02020-11-25T01:44:36ZengMDPI AGInternational Journal of Molecular Sciences1422-00672020-03-01216223510.3390/ijms21062235ijms21062235Synthesis, Anticancer Evaluation and Structure-Activity Analysis of Novel (<i>E</i>)- 5-(2-Arylvinyl)-1,3,4-oxadiazol-2-yl)benzenesulfonamidesKrzysztof Szafrański0Jarosław Sławiński1Łukasz Tomorowicz2Anna Kawiak3Department of Organic Chemistry, Faculty of Pharmacy, Medical University of Gdańsk, Al. Gen. J. Hallera 107, 80-416 Gdańsk, PolandDepartment of Organic Chemistry, Faculty of Pharmacy, Medical University of Gdańsk, Al. Gen. J. Hallera 107, 80-416 Gdańsk, PolandDepartment of Organic Chemistry, Faculty of Pharmacy, Medical University of Gdańsk, Al. Gen. J. Hallera 107, 80-416 Gdańsk, PolandDepartment of Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gdańsk and Medical University of Gdańsk, ul. Abrahama 58, 80-307 Gdańsk, PolandTo learn more about the structure−activity relationships of (<i>E</i>)-3-(5-styryl-1,3,4-oxadiazol-2-yl)benzenesulfonamide derivatives, which in our previous research displayed promising in vitro anticancer activity, we have synthesized a group of novel (<i>E</i>)-5-[(5-(2-arylvinyl)-1,3,4-oxadiazol-2-yl)]-4-chloro-2-R<sup>1</sup>-benzenesulfonamides <b>7</b>−<b>36</b> as well as (<i>E</i>)-4-[5-styryl1,3,4-oxadiazol-2-yl]benzenesulfonamides <b>47</b>−<b>50</b> and (<i>E</i>)-2-(2,4-dichlorophenyl)-5-(2-arylvinyl)-1,3,4-oxadiazols <b>51</b>−<b>55</b>. All target derivatives were evaluated for their anticancer activity on HeLa, HCT-116, and MCF-7 human tumor cell lines. The obtained results were analyzed in order to explain the influence of a structure of the 2-aryl-vinyl substituent and benzenesulfonamide scaffold on the anti-tumor activity. Compound <b>31</b>, bearing 5-nitrothiophene moiety, exhibited the most potent anticancer activity against the HCT-116, MCF-7, and HeLa cell lines, with IC50 values of 0.5, 4, and 4.5 µM, respectively. Analysis of structure-activity relationship showed significant differences in activity depending on the substituent in position 3 of the benzenesulfonamide ring and indicated as the optimal <i>meta</i> position of the sulfonamide moiety relative to the oxadizole ring. In the next stage, chemometric analysis was performed basing on a set of computed molecular descriptors. Hierarchical cluster analysis was used to examine the internal structure of the obtained data and the quantitative structure−activity relationship (QSAR) analysis with multiple linear regression (MLR) method allowed for finding statistically significant models for predicting activity towards all three cancer cell lines.https://www.mdpi.com/1422-0067/21/6/2235benzenesulfonamidesynthesis1,3,4-oxadiazoleanticancer activityqsarcluster analysis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Krzysztof Szafrański Jarosław Sławiński Łukasz Tomorowicz Anna Kawiak |
spellingShingle |
Krzysztof Szafrański Jarosław Sławiński Łukasz Tomorowicz Anna Kawiak Synthesis, Anticancer Evaluation and Structure-Activity Analysis of Novel (<i>E</i>)- 5-(2-Arylvinyl)-1,3,4-oxadiazol-2-yl)benzenesulfonamides International Journal of Molecular Sciences benzenesulfonamide synthesis 1,3,4-oxadiazole anticancer activity qsar cluster analysis |
author_facet |
Krzysztof Szafrański Jarosław Sławiński Łukasz Tomorowicz Anna Kawiak |
author_sort |
Krzysztof Szafrański |
title |
Synthesis, Anticancer Evaluation and Structure-Activity Analysis of Novel (<i>E</i>)- 5-(2-Arylvinyl)-1,3,4-oxadiazol-2-yl)benzenesulfonamides |
title_short |
Synthesis, Anticancer Evaluation and Structure-Activity Analysis of Novel (<i>E</i>)- 5-(2-Arylvinyl)-1,3,4-oxadiazol-2-yl)benzenesulfonamides |
title_full |
Synthesis, Anticancer Evaluation and Structure-Activity Analysis of Novel (<i>E</i>)- 5-(2-Arylvinyl)-1,3,4-oxadiazol-2-yl)benzenesulfonamides |
title_fullStr |
Synthesis, Anticancer Evaluation and Structure-Activity Analysis of Novel (<i>E</i>)- 5-(2-Arylvinyl)-1,3,4-oxadiazol-2-yl)benzenesulfonamides |
title_full_unstemmed |
Synthesis, Anticancer Evaluation and Structure-Activity Analysis of Novel (<i>E</i>)- 5-(2-Arylvinyl)-1,3,4-oxadiazol-2-yl)benzenesulfonamides |
title_sort |
synthesis, anticancer evaluation and structure-activity analysis of novel (<i>e</i>)- 5-(2-arylvinyl)-1,3,4-oxadiazol-2-yl)benzenesulfonamides |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2020-03-01 |
description |
To learn more about the structure−activity relationships of (<i>E</i>)-3-(5-styryl-1,3,4-oxadiazol-2-yl)benzenesulfonamide derivatives, which in our previous research displayed promising in vitro anticancer activity, we have synthesized a group of novel (<i>E</i>)-5-[(5-(2-arylvinyl)-1,3,4-oxadiazol-2-yl)]-4-chloro-2-R<sup>1</sup>-benzenesulfonamides <b>7</b>−<b>36</b> as well as (<i>E</i>)-4-[5-styryl1,3,4-oxadiazol-2-yl]benzenesulfonamides <b>47</b>−<b>50</b> and (<i>E</i>)-2-(2,4-dichlorophenyl)-5-(2-arylvinyl)-1,3,4-oxadiazols <b>51</b>−<b>55</b>. All target derivatives were evaluated for their anticancer activity on HeLa, HCT-116, and MCF-7 human tumor cell lines. The obtained results were analyzed in order to explain the influence of a structure of the 2-aryl-vinyl substituent and benzenesulfonamide scaffold on the anti-tumor activity. Compound <b>31</b>, bearing 5-nitrothiophene moiety, exhibited the most potent anticancer activity against the HCT-116, MCF-7, and HeLa cell lines, with IC50 values of 0.5, 4, and 4.5 µM, respectively. Analysis of structure-activity relationship showed significant differences in activity depending on the substituent in position 3 of the benzenesulfonamide ring and indicated as the optimal <i>meta</i> position of the sulfonamide moiety relative to the oxadizole ring. In the next stage, chemometric analysis was performed basing on a set of computed molecular descriptors. Hierarchical cluster analysis was used to examine the internal structure of the obtained data and the quantitative structure−activity relationship (QSAR) analysis with multiple linear regression (MLR) method allowed for finding statistically significant models for predicting activity towards all three cancer cell lines. |
topic |
benzenesulfonamide synthesis 1,3,4-oxadiazole anticancer activity qsar cluster analysis |
url |
https://www.mdpi.com/1422-0067/21/6/2235 |
work_keys_str_mv |
AT krzysztofszafranski synthesisanticancerevaluationandstructureactivityanalysisofnoveliei52arylvinyl134oxadiazol2ylbenzenesulfonamides AT jarosławsławinski synthesisanticancerevaluationandstructureactivityanalysisofnoveliei52arylvinyl134oxadiazol2ylbenzenesulfonamides AT łukasztomorowicz synthesisanticancerevaluationandstructureactivityanalysisofnoveliei52arylvinyl134oxadiazol2ylbenzenesulfonamides AT annakawiak synthesisanticancerevaluationandstructureactivityanalysisofnoveliei52arylvinyl134oxadiazol2ylbenzenesulfonamides |
_version_ |
1725027596241993728 |